The July 2021 edition of our Newsletter is now available. This issue includes an update on the Patented Medicine Prices Review Board (PMPRB) changes, the Nova Scotia 2021 Election Campaign, a Cancer Can’t-Wait update, upcoming events, and past webinars. Click here to view! Subscribe here for our Newsletter to ensure you receive future editions.
The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from patient groups and the pharmaceutical industry, which are concerned that the changes will result in fewer life-saving drugs being available in Canada. Rather than being open to dissenting voices and facilitating a constructive